SCHEMBL24025263

SCHEMBL24025263

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc4-n4c5ccccc5c5ccc6oc7ccccc7c6c54)n3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
MAPT P10636 4/20 0.32
TSHR P16473 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
LMNA P02545 2/20 0.31
POLB P06746 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
PGR P06401 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
CHEK2 O96017 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MAPK1 P28482 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22514607 0.99 PLA2G2A (0.34) PLA2G2APLA2G4AMAPTTSHRALDH1A1
SCHEMBL24025163 0.99 MAPT (0.32) PLA2G2APLA2G4AMAPTTSHRALDH1A1
SCHEMBL22514626 0.97 PLA2G2A (0.34) PLA2G2APLA2G4AMAPTTSHRALDH1A1
SCHEMBL22514354 0.97 PLA2G2A (0.33) PLA2G2APLA2G4AMAPTTSHRALDH1A1
SCHEMBL24025307 0.97 PLA2G2A (0.34) PLA2G2APLA2G4AMAPTTSHRALDH1A1
SCHEMBL24025007 0.95 KMT2A (0.38) MAPTTSHRALDH1A1HPGDLMNA
SCHEMBL22515149 0.95 MAPT (0.31) MAPTTSHRALDH1A1HPGDLMNA
SCHEMBL24224055 0.94 MAPT (0.33) PLA2G2APLA2G4AMAPTTSHRALDH1A1
SCHEMBL22514403 0.94 PLA2G2A (0.31) PLA2G2APLA2G4A
SCHEMBL24025182 0.94 ALDH1A1 (0.34) MAPTTSHRALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210355128-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210355128-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME NR2E3, CRY2, CRY1 PLA2G2A 3269/4885PLA2G4A 2991/4885MAPT 3522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.